Data as of Nov 28
| -0.65 / -1.08%|
The 12 analysts offering 12-month price forecasts for Hospira Inc have a median target of 56.50, with a high estimate of 65.00 and a low estimate of 44.00. The median estimate represents a -5.26% decrease from the last price of 59.64.
The current consensus among 15 polled investment analysts is to Hold stock in Hospira Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.